← Open Payments lookup

KEESHA STEWART: Open Payments

NPI 1235895269 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,744 in 89 payments from 17 companies in 2025. Trend: 2023 $2,692 · 2024 $2,154 · 2025 $1,744

Food & beverage: $1,740Education: $4
CompanyPaymentsAmount
Alkermes, Inc.16$314
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$246
Neurocrine BioSciences, Inc.9$190
Otsuka America Pharmaceutical, Inc.9$178
ABBVIE INC.9$152
Axsome Therapeutics, Inc.8$137
Vanda Pharmaceuticals Inc.4$109
Supernus Pharmaceuticals, Inc.4$77
Janssen Pharmaceuticals, Inc3$72
Teva Pharmaceuticals USA, Inc.4$66

Products named: ARISTADA, CAPLYTA, INGREZZA, REXULTI, VRAYLAR, Auvelity, FANAPT, Qelbree.

Industry payments across VA — which companies pay providers there.